The TCbHP breast cancer chemotherapy regimen is a dual-targeted treatment using docetaxel in combination with two chemotherapy drugs, carboplatin, along with trastuzumab and patuximab. TCbHP is a relatively common chemotherapy regimen in clinical practice, and can be used as part of the overall treatment program for breast cancer. However, the specific number of chemotherapy treatments, the interval between each chemotherapy treatment, as well as the order of medication and drug dosage may vary to some extent. In the treatment, patients need to go to the hospital for relevant examinations, combined with the physical condition, the doctor will formulate an appropriate chemotherapy program for treatment.TCbHP chemotherapy program, although some patients have drug resistance to trastuzumab, but the addition of patuximab can reduce the incidence of drug resistance in patients. Please strictly follow the doctor’s instructions, do not self-medicate.